Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites

Lancet. 2004 May 15;363(9421):1608-10. doi: 10.1016/S0140-6736(04)16206-5.

Abstract

Serum lipopolysaccharide-binding protein is increased in a subset of non-infected ascitic cirrhotic patients, a finding previously related to bacterial passage from the gut to the circulation without overt infection. We prospectively analysed the risk factors associated with a first episode of severe bacterial infection in 84 ascitic cirrhotics, followed up for a median of 46 weeks. The cumulative probability of such infection in patients with raised and normal lipopolysaccharide-binding protein was 32.4% and 8.0% (p=0.004), respectively. Increased lipopolysaccharide-binding protein was the only factor independently associated with severe bacterial infection in a multivariate analysis (relative risk 4.49, 95% CI 1.42-14.1). Monitoring of serum lipopolysaccharide-binding protein could, therefore, help to target cirrhotic patients with ascites for antibiotic prophylaxis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute-Phase Proteins / analysis*
  • Ascites / complications*
  • Bacteremia / complications
  • Bacteremia / diagnosis
  • Bacterial Infections / blood
  • Bacterial Infections / complications
  • Bacterial Infections / diagnosis*
  • Biomarkers / blood
  • Carrier Proteins / blood*
  • Humans
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / microbiology*
  • Membrane Glycoproteins*
  • Models, Statistical
  • Peritonitis / complications
  • Peritonitis / diagnosis
  • Pneumonia, Bacterial / complications
  • Pneumonia, Bacterial / diagnosis
  • Risk Factors

Substances

  • Acute-Phase Proteins
  • Biomarkers
  • Carrier Proteins
  • Membrane Glycoproteins
  • lipopolysaccharide-binding protein